Mesoblast MESO Peer Comparison

NASDAQ MESO
$17.33 +0.19 (+1.14%)
As of: Sep 4, 2026 · 3:58 PM EDT
Peer Comparison

115 Comparable Companies

Industry Gene and Cell Therapy

Mesoblast Ltd (MESO) is the 19th largest of 115 Gene and Cell Therapy companies by market capitalisation, at 2.24 Bn, behind Sarepta Therapeutics, Inc. at 2.36 Bn. The table below compares all 115 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 KRYS Krystal Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 10.61 Bn 43.92 24.07 9.76 Bn
2 CRSP CRISPR Therapeutics AG primary H-03 Pharmaceuticals and Biotechnology HG-01 5.39 Bn -11.15 402.57 5.39 Bn
3 LEGN Legend Biotech Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 3.97 Bn -188.37 3.12 3.00 Bn
4 IOVA Iovance Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.95 Bn -18.92 12.17 3.66 Bn
5 BEAM Beam Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.10 Bn -36.27 19.86 3.10 Bn
6 QURE uniQure N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.98 157.84 2.95 Bn
7 PGEN Precigen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -7.52 29.54 2.53 Bn
8 SRPT Sarepta Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -17.23 1.20 1.57 Bn
9 MESO Mesoblast Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -38.60 18.46 2.14 Bn
10 TSHA Taysha Gene Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -13.80 376.45 2.06 Bn
11 VCEL Vericel Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 2.05 Bn 81.70 6.69 1.89 Bn
12 NTLA Intellia Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -4.25 28.53 1.70 Bn
13 SLDB Solid Biosciences Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -7.27 — 1.48 Bn
14 MGTX MeiraGTx Holdings plc primary H-03 Pharmaceuticals and Biotechnology HG-01 1.27 Bn 7.69 3.17 1.13 Bn
15 IMTX Immatics N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -4.85 24.04 0.71 Bn
16 SANA Sana Biotechnology, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -5.32 — 1.14 Bn
17 FDMT 4D Molecular Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.05 Bn -5.88 11.45 0.69 Bn
18 CADL Candel Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -14.49 — 0.95 Bn
19 IMMX Immix Biopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.89 Bn -28.10 — 0.89 Bn
20 NGNE Neurogene Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -7.74 — 0.86 Bn
21 PRME Prime Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -3.48 160.56 0.65 Bn
22 ALLO Allogene Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -3.91 139.65 0.65 Bn
23 AUTL Autolus Therapeutics plc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -2.32 5.31 0.39 Bn
24 BNTC Benitec Biopharma Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -12.72 — 0.59 Bn
25 CAPR Capricor Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -4.30 — 0.54 Bn
26 CABA Cabaletta Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -2.85 — 0.52 Bn
27 KYTX Kyverna Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -3.31 — 0.51 Bn
28 RGNX REGENXBIO Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -2.67 2.50 0.37 Bn
29 OCGN Ocugen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -5.61 100.20 0.36 Bn
30 IRD Opus Genetics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.60 45.34 0.36 Bn
31 ARTV Artiva Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.86 — 0.44 Bn
32 IPSC Century Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.01 — 0.18 Bn
33 RCKT Rocket Pharmaceuticals, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -25.35 — 0.44 Bn
34 LXEO Lexeo Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.80 — 0.42 Bn
35 PROK Prokidney Corp. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -2.84 464.12 0.38 Bn
36 ABEO Abeona Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -3.16 13.41 0.20 Bn
37 LYEL Lyell Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -1.36 12,443.49 0.34 Bn
38 CLLS Cellectis S.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -9.71 5.47 0.16 Bn
39 FATE Fate Therapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.39 46.19 0.30 Bn
40 EDIT Editas Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.29 Bn — — 0.14 Bn
41 NWBO Northwest Biotherapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -7.16 128.04 0.28 Bn
42 RNAC Cartesian Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -2.50 184.14 0.27 Bn
43 LCTX Lineage Cell Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -11.80 20.69 0.21 Bn
44 TARA Protara Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.43 — 0.24 Bn
45 NKTX Nkarta, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.52 — 0.22 Bn
46 VYGR Voyager Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.56 6.11 0.09 Bn
47 DTIL Precision Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -5.69 4.29 0.11 Bn
48 CRBU Caribou Biosciences, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -1.44 15.70 0.05 Bn
49 TNYA Tenaya Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.44 111.46 0.15 Bn
50 ZSQR Z Squared Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -7.64 52.66 0.13 Bn
51 ATRA Atara Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.25 23.71 0.13 Bn
52 HUMA Humacyte, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.18 66.64 0.14 Bn
53 ENGN enGene Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.00 — 0.13 Bn
54 ACET Adicet Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -1.04 — -0.02 Bn
55 ANIX Anixa Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.92 — 0.10 Bn
56 INMB Inmune Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.18 — 0.05 Bn
57 INKT MiNK Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -5.00 — 0.06 Bn
58 APTN Adaptin Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -10.22 — 0.06 Bn
59 TCRX TScan Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.44 7.27 0.05 Bn
60 SGMOQ Sangamo Therapeutics, Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.36 1.13 0.02 Bn
61 CELU Celularity Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.48 1.66 0.04 Bn
62 MGX Metagenomi Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 2.02 0.04 Bn
63 ESLA Estrella Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.79 — 0.03 Bn
64 TVGN Tevogen Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.21 — 0.03 Bn
65 INAB In8Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.29 — 0.02 Bn
66 MRKR Marker Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.26 — 0.01 Bn
67 LGVN Longeveron Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.91 18.17 0.01 Bn
68 GNTA Genenta Science S.p.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.83 — -0.01 Bn
69 PASG Passage BIO, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.39 — 0.02 Bn
70 ADIA Adia Nutrition, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -75.51 69.62 0.01 Bn
71 PLUR Pluri Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.00 9.06 0.00 Bn
72 FBLG FibroBiologics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.67 — 0.01 Bn
73 SNTI Senti Biosciences Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.16 622.71 0.01 Bn
74 GDTC CytoMed Therapeutics Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.36 41.92 0.01 Bn
75 ZEOX Zeo ScientifiX, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -2.21 1.34 0.01 Bn
76 LNAI Lunai Bioworks Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.05 86.37 0.00 Bn
77 TPST Tempest Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.28 — 0.00 Bn
78 PMCB PharmaCyte Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 — 0.00 Bn
79 MBIO Mustang Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.20 — 0.00 Bn
80 ISCO International Stem Cell CORP primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -9.66 0.32 0.00 Bn
81 CLDI Calidi Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.08 — 0.00 Bn
82 GNPX Genprex, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
83 CELZ Creative Medical Technology Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 517.47 0.00 Bn
84 RMTG Regenerative Medical Technology Group Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 0.12 0.00 Bn
85 ERNAW Ernexa Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
86 BRTX BioRestorative Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.18 0.00 Bn
87 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.34 Bn 31.53 6.77 642.58 Bn
88 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn -64.72 6.15 184.18 Bn
89 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.47 Bn 31.43 11.00 130.62 Bn
90 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.48 Bn -31.39 24.15 26.32 Bn
91 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.18 Bn -16.97 2,305.26 25.18 Bn
92 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 20.83 Bn 15.89 6.60 18.16 Bn
93 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.76 Bn 22.33 4.67 15.37 Bn
94 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.51 3.78 12.01 Bn
95 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.58 51.33 8.15 Bn
96 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 18.05 9.97 7.29 Bn
97 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.01 1.63 1.88 Bn
98 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.56 Bn -3.38 2.18 1.27 Bn
99 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.04 Bn 71.36 1.40 0.79 Bn
100 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.80 — 0.45 Bn
101 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 3.73 2.58 0.34 Bn
102 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.03 0.01 -10.79 Bn
103 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.11 19.66 0.10 Bn
104 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.47 — 0.14 Bn
105 GUTS Fractyl Health, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.11 Bn -0.86 — 0.11 Bn
106 PLYX Polaryx Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.70 — 0.09 Bn
107 FBIO Fortress Biotech, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 10.39 1.26 -0.11 Bn
108 SER Serina Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.57 341.56 0.02 Bn
109 ATNM Actinium Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 2.86 0.92 0.03 Bn
110 CTXR Citius Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.15 0.02 Bn
111 CASIF CASI Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
112 GOVX GeoVax Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 2.67 0.00 Bn
113 RNAZ Transcode Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.04 — 0.00 Bn
114 BCAB BioAtla, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 0.24 0.00 Bn
115 GRMLW Greenland Mines Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 — -0.01 Bn